Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation - Millán, Olga; Rovira, Jordi; Guirado, Lluis; Espinosa, Cristina; Budde, Klemens; Sommerer, Claudia; Piñeiro, Gaston J.; Diekmann, Fritz; Brunet, Mercè (Clinical immunology, 2021)
Gesehen am 21.10.2021